Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
As of today, Pfizer(PFE) shares are valued at $25.68. The company's market cap stands at 146.33B, with a P/E ratio of 19.96 and a dividend yield of 6.6%.
On 2026-06-08, Pfizer(PFE) stock moved within a range of $25.61 to $26.22. With shares now at $25.68, the stock is trading +0.3% above its intraday low and -2.1% below the session's peak.
Trading activity shows a volume of 24.94M, compared to an average daily volume of 32.57M.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.75 and a low of $23.11.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.75 and a low of $23.11.
PFE News
...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer-Backed Bladder Cancer Study Pits Novel Combo Against Standard Care This Phase 3 t...
Pfizer (PFE) announced that the U.S. FDA has approved an expanded indication for Hympavzi to include the treatment of patients with hemophilia A or B 12 years a...
Analyst ratings
55%
of 29 ratingsMore PFE News
Pfizer (PFE) presented detailed results from multiple Phase 2b studies of berobenatide, an investigational, potential first-in-class monthly GLP-1 receptor agon...
Key Points Pfizer’s net income is under pressure, and likely will be for the foreseeable future. Although its replenished pipeline and portfolio should help,...
Key Points Pfizer is a highly respected pharmaceutical company. The drug maker is dealing with a mismatch between its new drug development and patent expirati...
Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Claim 55% Off TipRanks Unlock trusted, data-backed i...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings a...
In late May and early June 2026, Pfizer reported detailed Phase 3 data at ASCO showing its BRAFTOVI, TALZENNA and LORBRENA regimens delivered statistically sign...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings a...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.